Medication review with follow-up for cardiovascular outcomes: A trial based cost-utility analysis

Simple item page
dc.article.number102546
dc.article.number102546
dc.contributor.authorAhumada-Canale A.
dc.contributor.authorMartinez-Mardones F.
dc.contributor.authorGarcia-Cardenas V.
dc.contributor.authorAhumada-Canale A.
dc.contributor.authorVargas C.
dc.contributor.authorBalmaceda C.
dc.contributor.authorPlaza-Plaza J.C.
dc.contributor.authorBenrimoj S.
dc.date.accessioned2025-05-01T10:32:03Z
dc.date.available2025-05-01T10:32:03Z
dc.date.issued2021
dc.description.abstract© 2021 Future Medicine Ltd.. All rights reserved.Aim: To assess the trial-based cost-effectiveness of medication review with follow-up compared with usual care in primary care. Materials methods: A cluster randomized controlled trial included patients if they were independent older adults, receiving five or more prescriptions, with moderate or high cardiovascular risk. Costs were estimated from the public healthcare sector perspective, and health benefits were measured as quality-Adjusted life years. Both of which were used to calculate the incremental cost-effectiveness ratio. Results: Twelve centers completed the study, six (146 patients) in the intervention group and six (145 patients) in the control group. The base-case analysis showed an incremental cost-effectiveness ratio of US (2019) 434.4/quality-Adjusted life year (95% CI 64.20-996.03). Conclusion: The intervention was cost-effective in the public primary care setting.
dc.description.funderFONDECYT
dc.description.funderMarine Energy Research & Innovation Center
dc.format.extent15 páginas
dc.fuente.origenScopus
dc.identifier.doi10.2217/cer-2020-0171
dc.identifier.eisbn978-84-9880-797-4
dc.identifier.eissn20426313
dc.identifier.isbn978-0-12-817240-7
dc.identifier.issn20426313 20426305
dc.identifier.pubmedid33543637
dc.identifier.scieloidS0718-69242020000300109
dc.identifier.scopusidSCOPUS_ID:85101083686
dc.identifier.urihttps://doi.org/10.2217/cer-2020-0171
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/103816
dc.identifier.wosidWOS:000614883200001
dc.information.autorucESCUELA QUÍMICA Y FARMACIA; Plaza Plaza Jose Cristian; S/I; 10012
dc.issue.numero3515
dc.language.isoen
dc.nota.accesoSin adjunto
dc.pagina.final242
dc.pagina.inicio229
dc.publisherAcademic Press
dc.relation.ispartof7th Workshop On Educational Innovation In Architecture (JIDA), NOV 14-15, 2019, Madrid, SPAIN
dc.revistaJournal of Comparative Effectiveness Research
dc.rightsAcceso cerrado
dc.subjectaged
dc.subjectcardiovascular system
dc.subjectcost-effectiveness
dc.subjectdrug monitoring
dc.subjecteconomics
dc.subjectpharmacy
dc.subject.ddc510
dc.subject.deweyMatemática física y químicaes_ES
dc.subject.ods02 Zero hunger
dc.subject.odspa02 Hambre cero
dc.titleMedication review with follow-up for cardiovascular outcomes: A trial based cost-utility analysis
dc.typeartículo
dc.volumen10
sipa.codpersvinculados10012
sipa.indexWOS
sipa.indexScopus
sipa.indexPubmed
sipa.trazabilidadCarga WOS-SCOPUS;01-05-2025
Files
Collections
Artículos de revistas